Autopsy report · NCT02474706

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli

“Lack of recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 1 year 9 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Central Hospital, Nancy, France

Sponsor type

University, hospital or other

Conditions

Urinary Tract Infections

Interventions

Cefoxitin; imipenem

Participants

6

Sites

1

Countries

France

Trials that died the same way

• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  “lacking recruitment” (96% match in meaning)
• Expanding Access to Comprehensive Geriatrics Care Via Telehealth
  “Inadequate recruitment” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.